Diego Centonze
Affiliations: |
Google:
"Diego Centonze"Mean distance: 15.95 (cluster 6)
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Stampanoni Bassi M, Iezzi E, Centonze D. (2022) Multiple sclerosis: Inflammation, autoimmunity and plasticity. Handbook of Clinical Neurology. 184: 457-470 |
| Ziccardi L, Barbano L, Boffa L, et al. (2020) Morphological Outer Retina Findings in Multiple Sclerosis Patients With or Without Optic Neuritis. Frontiers in Neurology. 11: 858 |
| Stampanoni Bassi M, Buttari F, Gilio L, et al. (2020) Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective. Frontiers in Neurology. 11: 566 |
| Chisari CG, Solaro C, Annunziata P, et al. (2020) Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study. Journal of Neurology, Neurosurgery, and Psychiatry |
| Bruno A, Dolcetti E, Rizzo FR, et al. (2020) Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis. Frontiers in Cellular Neuroscience. 14: 169 |
| Stampanoni Bassi M, Iezzi E, Drulovic J, et al. (2020) IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis. Frontiers in Cellular Neuroscience. 14: 120 |
| Sørensen PS, Centonze D, Giovannoni G, et al. (2020) Expert opinion on the use of cladribine tablets in clinical practice. Therapeutic Advances in Neurological Disorders. 13: 1756286420935019 |
| Farini D, Cesari E, Weatheritt RJ, et al. (2020) A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum. Cell Reports. 31: 107703 |
| Musella A, Gentile A, Guadalupi L, et al. (2020) Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis. Cells. 9 |
| Patti F, Chisari CG, D'Amico E, et al. (2020) Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study). Multiple Sclerosis and Related Disorders. 42: 102124 |